Bank of New York Mellon’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$285K Buy
390,313
+1,192
+0.3% +$872 ﹤0.01% 3808
2025
Q1
$314K Sell
389,121
-1,881
-0.5% -$1.52K ﹤0.01% 3663
2024
Q4
$540K Buy
391,002
+82,222
+27% +$113K ﹤0.01% 3463
2024
Q3
$321K Sell
308,780
-80,445
-21% -$83.7K ﹤0.01% 3721
2024
Q2
$673K Buy
389,225
+80,222
+26% +$139K ﹤0.01% 3402
2024
Q1
$739K Sell
309,003
-45,268
-13% -$108K ﹤0.01% 3306
2023
Q4
$1.18M Sell
354,271
-41,256
-10% -$137K ﹤0.01% 3103
2023
Q3
$1.48M Sell
395,527
-194,521
-33% -$728K ﹤0.01% 2966
2023
Q2
$2.52M Buy
590,048
+29,148
+5% +$124K ﹤0.01% 2706
2023
Q1
$3.84M Sell
560,900
-18,508
-3% -$127K ﹤0.01% 2443
2022
Q4
$4.59M Sell
579,408
-44,483
-7% -$352K ﹤0.01% 2387
2022
Q3
$6M Buy
623,891
+44,580
+8% +$428K ﹤0.01% 2193
2022
Q2
$4.19M Sell
579,311
-17,734
-3% -$128K ﹤0.01% 2401
2022
Q1
$7.71M Sell
597,045
-112,239
-16% -$1.45M ﹤0.01% 2217
2021
Q4
$11.3M Sell
709,284
-105,087
-13% -$1.68M ﹤0.01% 2036
2021
Q3
$13.1M Buy
814,371
+23,272
+3% +$374K ﹤0.01% 1970
2021
Q2
$10.9M Sell
791,099
-38,526
-5% -$533K ﹤0.01% 2086
2021
Q1
$12.1M Buy
829,625
+5,389
+0.7% +$78.7K ﹤0.01% 1985
2020
Q4
$14.3M Buy
824,236
+114,070
+16% +$1.98M ﹤0.01% 1812
2020
Q3
$13M Buy
710,166
+5,010
+0.7% +$91.9K ﹤0.01% 1707
2020
Q2
$12.6M Buy
705,156
+428,210
+155% +$7.65M ﹤0.01% 1696
2020
Q1
$4.49M Sell
276,946
-1,425
-0.5% -$23.1K ﹤0.01% 2123
2019
Q4
$5.01M Buy
278,371
+5,632
+2% +$101K ﹤0.01% 2344
2019
Q3
$5.53M Sell
272,739
-42,815
-14% -$867K ﹤0.01% 2234
2019
Q2
$6.97M Buy
315,554
+90,856
+40% +$2.01M ﹤0.01% 2180
2019
Q1
$3.06M Buy
224,698
+2,156
+1% +$29.4K ﹤0.01% 2567
2018
Q4
$2.01M Buy
222,542
+8,766
+4% +$79.3K ﹤0.01% 2719
2018
Q3
$3.53M Buy
213,776
+27,489
+15% +$454K ﹤0.01% 2556
2018
Q2
$2.61M Buy
186,287
+9,299
+5% +$130K ﹤0.01% 2709
2018
Q1
$1.96M Buy
176,988
+11,065
+7% +$122K ﹤0.01% 2818
2017
Q4
$1.46M Sell
165,923
-7,618
-4% -$67K ﹤0.01% 3018
2017
Q3
$2.32M Buy
173,541
+3,701
+2% +$49.4K ﹤0.01% 2758
2017
Q2
$2.44M Buy
169,840
+4,700
+3% +$67.4K ﹤0.01% 2735
2017
Q1
$3.49M Buy
165,140
+25,108
+18% +$531K ﹤0.01% 2515
2016
Q4
$3.94M Buy
140,032
+5,905
+4% +$166K ﹤0.01% 2456
2016
Q3
$3.59M Sell
134,127
-3,730
-3% -$99.9K ﹤0.01% 2410
2016
Q2
$2.33M Buy
137,857
+36,650
+36% +$619K ﹤0.01% 2617
2016
Q1
$2.15M Buy
101,207
+18,272
+22% +$388K ﹤0.01% 2615
2015
Q4
$1.9M Sell
82,935
-1,547
-2% -$35.5K ﹤0.01% 2737
2015
Q3
$1.69M Sell
84,482
-10,427
-11% -$209K ﹤0.01% 2829
2015
Q2
$2.74M Buy
94,909
+38,084
+67% +$1.1M ﹤0.01% 2712
2015
Q1
$1.74M Buy
56,825
+40,073
+239% +$1.23M ﹤0.01% 2967
2014
Q4
$273K Buy
+16,752
New +$273K ﹤0.01% 3805